» Articles » PMID: 33030518

Association of Study Methods and Industry Sponsorship With Inconsistent Performance of Molecular Assays for Indeterminate Thyroid Nodules

Overview
Authors
Affiliations
Soon will be listed here.
References
1.
Taye A, Gurciullo D, Miles B, Gupta A, Owen R, Inabnet 3rd W . Clinical performance of a next-generation sequencing assay (ThyroSeq v2) in the evaluation of indeterminate thyroid nodules. Surgery. 2017; 163(1):97-103. DOI: 10.1016/j.surg.2017.07.032. View

2.
Marti J, Avadhani V, Donatelli L, Niyogi S, Wang B, Wong R . Wide Inter-institutional Variation in Performance of a Molecular Classifier for Indeterminate Thyroid Nodules. Ann Surg Oncol. 2015; 22(12):3996-4001. PMC: 4923939. DOI: 10.1245/s10434-015-4486-3. View

3.
Nikiforov Y, Seethala R, Tallini G, Baloch Z, Basolo F, Thompson L . Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. JAMA Oncol. 2016; 2(8):1023-9. PMC: 5539411. DOI: 10.1001/jamaoncol.2016.0386. View

4.
Cibas E, Ali S . The Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2009; 19(11):1159-65. DOI: 10.1089/thy.2009.0274. View

5.
Valderrabano P, Hallanger-Johnson J, Thapa R, Wang X, McIver B . Comparison of Postmarketing Findings vs the Initial Clinical Validation Findings of a Thyroid Nodule Gene Expression Classifier: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg. 2019; 145(9):783-792. PMC: 6647006. DOI: 10.1001/jamaoto.2019.1449. View